1382. Deputy Joe Carey asked the Minister for Health if he will ensure that the health technology assessment dossier covering kaftrio in combination with ivacaftor for the cohort of 35 children aged 6 to 11 years with certain mutations in the cystic fibrosis transmembrane conductance regulator gene which was submitted to the National Centre for Pharmacoeconomics on 21 December 2022 moves as expeditiously as possible, with appropriate input from the patient community thereby giving access to this life changing drug for these vulnerable children at the earliest opportunity; and if he will make a statement on the matter. [1024/23]

Summary

1382. Deputy Joe Carey asked the Minister for Health if he will ensure that the health technology assessment dossier covering kaftrio in combination with ivacaftor for the cohort of 35 children aged 6 to 11 years with certain mutations in the cystic fibrosis transmembrane conductance regulator gene which was submitted to the National Centre for Pharmacoeconomics on 21 December 2022 moves as expeditiously as possible, with appropriate input from the patient community thereby giving access to this life changing drug for these vulnerable children at the earliest opportunity; and if he will make a statement on the matter. [1024/23]

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

1 official file

• Medicinal Products

  xml · EN · 18 January 2023

  ViewDownloadOpen at official source

Sponsors

No sponsors or actors listed by the source.

Related records

No cross-record relationships stored yet.